A plan by UBS and China Life Insurance Group to set up an asset management joint venture in China faces uncertainty as talks have stalled due to a corruption investigation at the insurer and curbs set on the scope of the business, two sources said.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
